News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Abingworth LLP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2022 |
SC 13D/A
| Abingworth LLP reports a 4.4% stake in Verona Pharma plc |
| 07/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/08/2022 |
SC 13D/A
| Abingworth LLP reports a 15.3% stake in Soleno Therapeutics Inc. |
| 04/07/2022 |
SC 13D/A
| Abingworth LLP reports a 11.1% stake in Vera Therapeutics, Inc. |
| 03/21/2022 |
SC 13D/A
| Abingworth LLP reports a 8.9% stake in Sierra Oncology, Inc. |
| 02/25/2022 |
SC 13D/A
| Abingworth LLP reports a 6.5% stake in Exicure, Inc. |
| 02/10/2022 |
SC 13D/A
| Abingworth LLP reports a 11.3% stake in Sierra Oncology, Inc. |
| 11/05/2021 |
SC 13D/A
| Abingworth LLP reports a 12.6% stake in Sierra Oncology, Inc. |
| 03/16/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/31/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/06/2020 |
SC 13D/A
| Abingworth LLP reports a 13.2% stake in Soleno Therapeutics Inc. |
| 01/17/2020 |
SC 13D/A
| Abingworth LLP reports a 1.9% stake in ArTara Therapeutics, Inc. |
| 11/14/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/17/2019 |
SC 13D/A
| Abingworth LLP reports a 4.9% stake in SIENTRA, INC. |
| 05/09/2018 |
SC 13D/A
| Abingworth LLP reports a 8.9% stake in SIENTRA, INC. |
| 01/16/2018 |
SC 13D/A
| Abingworth LLP reports a 4% stake in CRISPR Therapeutics AG |
| 08/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/27/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/23/2017 |
SC 13D/A
| Lombard Medical, Inc. reports a 12.4% stake in LOMBARD MEDICAL, INC. |
| 11/22/2016 |
SC 13D/A
| Dicerna Pharmaceuticals Inc reports a 3.9% stake in DICERNA PHARMACEUTICALS, INC. |
| 07/22/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/27/2012 |
SC 13D/A
| Abingworth LLP reports a 7% stake in AMARIN CORPORATION PLC |
| 10/20/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/06/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/16/2011 |
SC 13D/A
| Abingworth LLP reports a 10% stake in AMARIN CORPORATION PLC |
| 01/21/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 12/23/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 10/28/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|